Atlantic Union Bankshares’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93K Hold
382
﹤0.01% 1507
2025
Q4
$757 Hold
382
﹤0.01% 1589
2025
Q3
$940 Sell
382
-382
-50% -$984 ﹤0.01% 1530
2025
Q2
$2.02K Buy
+764
New +$2.05K ﹤0.01% 1085

Other funds holding IBRX

Atlantic Union Bankshares's IBRX Position: Q1 2026 in Review

Atlantic Union Bankshares held its ImmunityBio (IBRX) position steady in Q1 2026 at 382 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Atlantic Union Bankshares first reported a position in IBRX in Q2 2025 and has held it in 4 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Atlantic Union Bankshares held 382 shares of ImmunityBio worth $2.93K as of Q1 2026.
  • Atlantic Union Bankshares left its ImmunityBio share count unchanged in Q1 2026.
  • ImmunityBio made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #1507 holding.
  • Atlantic Union Bankshares first reported a position in ImmunityBio in Q2 2025 and has held it in 4 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.